Journal of Biological Chemistry · 2010 · 88 citations · 42 references
Life SciencesBiochemistryMolecular BiologyCell SignalingGene ExpressionSignal TransductionMuscle DevelopmentMuscle DifferentiationMuscle PhysiologyMuscle AtrophyMuscle Atrophy MechanismsMuscle Fiber AtrophyPhosphodiesterase RegulationSkeletal Muscle AtrophySkeletal Muscle DifferentiationSkeletal Muscle PhysiologyTransgenic Mice
Mammalian glycerophosphodiester phosphodiesterases (GP-PDEs) have been identified recently and shown to be implicated in several physiological functions. This study isolated a novel GP-PDE, GDE5, and showed that GDE5 selectively hydrolyzes glycerophosphocholine (GroPCho) and controls skeletal muscle development. We show that GDE5 expression was reduced in atrophied skeletal muscles in mice and that decreasing GDE5 abundance promoted myoblastic differentiation, suggesting that decreased GDE5 expression has a counter-regulatory effect on the progression of skeletal muscle atrophy. Forced expression of full-length GDE5 in cultured myoblasts suppressed myogenic differentiation. Unexpectedly, a truncated GDE5 construct (GDE5ΔC471), which contained a GP-PDE sequence identified in other GP-PDEs but lacked GroPCho phosphodiesterase activity, showed a similar inhibitory effect. Furthermore, transgenic mice specifically expressing GDE5ΔC471 in skeletal muscle showed less skeletal muscle mass, especially type II fiber-rich muscle. These results indicate that GDE5 negatively regulates skeletal muscle development even without GroPCho phosphodiesterase activity, providing novel insight into the biological significance of mammalian GP-PDE function in a non-enzymatic mechanism. Mammalian glycerophosphodiester phosphodiesterases (GP-PDEs) have been identified recently and shown to be implicated in several physiological functions. This study isolated a novel GP-PDE, GDE5, and showed that GDE5 selectively hydrolyzes glycerophosphocholine (GroPCho) and controls skeletal muscle development. We show that GDE5 expression was reduced in atrophied skeletal muscles in mice and that decreasing GDE5 abundance promoted myoblastic differentiation, suggesting that decreased GDE5 expression has a counter-regulatory effect on the progression of skeletal muscle atrophy. Forced expression of full-length GDE5 in cultured myoblasts suppressed myogenic differentiation. Unexpectedly, a truncated GDE5 construct (GDE5ΔC471), which contained a GP-PDE sequence identified in other GP-PDEs but lacked GroPCho phosphodiesterase activity, showed a similar inhibitory effect. Furthermore, transgenic mice specifically expressing GDE5ΔC471 in skeletal muscle showed less skeletal muscle mass, especially type II fiber-rich muscle. These results indicate that GDE5 negatively regulates skeletal muscle development even without GroPCho phosphodiesterase activity, providing novel insight into the biological significance of mammalian GP-PDE function in a non-enzymatic mechanism. IntroductionThe mass and composition of skeletal muscle are closely associated with its physiological functions, such as exercise, energy expenditure, and glucose metabolism (1Zurlo F. Larson K. Bogardus C. Ravussin E. J. Clin. Investig. 1990; 86: 1423-1427Crossref PubMed Scopus (621) Google Scholar, 2Berchtold M.W. Brinkmeier H. Müntener M. Physiol. Rev. 2000; 80: 1215-1265Crossref PubMed Scopus (682) Google Scholar). Progressive muscle loss, frequently caused by diabetes, obesity, and decreased physical activity (sarcopenia), is a major health problem in our aging society (3Proctor D.N Balagopal P Nair K.S J. Nutr. 1998; 128: S351-S355Crossref PubMed Google Scholar). In the search for clues as to the regulation of skeletal muscle mass and composition during physical exercise and muscular atrophy caused by disease and disuse, a number of metabolites have been investigated in adult skeletal muscles. In human and mouse skeletal muscle tissues, deacylated glycerophospholipids, the glycerophosphodiesters (GPs), 3The abbreviations used are: GPglycerophosphodiesterGP-PDEglycerophosphodiester phosphodiesteraseGroPInsglycerophosphoinositolGroPChoglycerophosphocholineESTexpressed sequence tagG3Pglycerol 3-phosphateMBPmaltose-binding protein. were analyzed as phosphate-containing compounds, and interestingly, the amounts of skeletal muscle GPs are reportedly altered in response to physical activity, the environment, and pathological conditions (4Burt C.T. Glonek T. Bárány M. Biochemistry. 1976; 15: 4850-4853Crossref PubMed Scopus (110) Google Scholar, 5Younkin D.P. Berman P. Sladky J. Chee C. Bank W. Chance B. Neurology. 1987; 37: 165-169Crossref PubMed Google Scholar, 6Sprott H. Rzanny R. Reichenbach J.R. Kaiser W.A. Hein G. Stein G. Rheumatology. 2000; 39: 1121-1125Crossref PubMed Scopus (39) Google Scholar). However, the biological functions of skeletal muscle GPs and the physiological regulation of their levels have not been studied to date.The GPs (primarily glycerophosphoinositol and glycerophosphocholine) are cellular products of phospholipase activities on membrane phospholipids. GP intracellular concentrations vary with oncogenic transformation, cell differentiation, and environmental stimuli, and they are thought to be tightly controlled for the balance between synthesis and degradation (7Baburina I. Jackowski S. J. Biol. Chem. 1999; 274: 9400-9408Abstract Full Text Full Text PDF PubMed Scopus (165) Google Scholar, 8Gallazzini M. Burg M.B. Physiology. 2009; 24: 245-249Crossref PubMed Scopus (46) Google Scholar, 9Corda D. Zizza P. Varone A. Filippi B.M. Mariggiò S. Cell. Mol. Life Sci. 2009; 66: 3449-3467Crossref PubMed Scopus (27) Google Scholar). For GP hydrolysis, two bacterial enzymes have been isolated and studied in depth at the molecular level. Glycerophosphodiester phosphodiesterases (GP-PDEs), GlpQ and UgpQ, were identified as periplasmic and cytosolic proteins that have essential roles in the hydrolysis of GPs to glycerol 3-phosphate and alcohol, which are used as major sources of carbon and phosphate (10Larson T.J. Ehrmann M. Boos W. J. Biol. Chem. 1983; 258: 5428-5432Abstract Full Text PDF PubMed Google Scholar, 11Tommassen J. Eiglmeier K. Cole S.T. Overduin P. Larson T.J. Boos W. Mol Gen Genet. 1991; 226: 321-327Crossref PubMed Scopus (71) Google Scholar). In contrast, three mammalian GP-PDEs, GDE1, GDE2, and GDE3, were previously identified and presumed to have distinct physiological functions (12Zheng B. Chen D. Farquhar M.G. Proc. Natl. Acad. Sci. U.S.A. 2000; 97: 3999-4004Crossref PubMed Scopus (56) Google Scholar, 13Yanaka N. Imai Y. Kawai E. Akatsuka H. Wakimoto K. Nogusa Y. Kato N. Chiba H. Kotani E. Omori K. Sakurai N. J. Biol. Chem. 2003; 278: 43595-43602Abstract Full Text Full Text PDF PubMed Scopus (38) Google Scholar, 14Nogusa Y. Fujioka Y. Komatsu R. Kato N. Yanaka N. Gene. 2004; 337: 173-179Crossref PubMed Scopus (26) Google Scholar, 15Rao M. Sockanathan S. Science. 2005; 309: 2212-2215Crossref PubMed Scopus (69) Google Scholar). In initial studies, GDE1 (also known as MIR16) was isolated as a unique membrane protein that interacted with RGS16, a regulator of G-protein signaling (12Zheng B. Chen D. Farquhar M.G. Proc. Natl. Acad. Sci. U.S.A. 2000; 97: 3999-4004Crossref PubMed Scopus (56) Google Scholar), and it has been shown to preferentially hydrolyze glycerophosphoinositol (GroPIns) in response to β-adrenergic stimulation (16Zheng B. Berrie C.P. Corda D. Farquhar M.G. Proc. Natl. Acad. Sci. U.S.A. 2003; 100: 1745-1750Crossref PubMed Scopus (69) Google Scholar). Studies on GDE2 show that retinoic acid-induced expression of GDE2 has critical roles in neuronal differentiation and neurite outgrowth of motor neurons (15Rao M. Sockanathan S. Science. 2005; 309: 2212-2215Crossref PubMed Scopus (69) Google Scholar, 17Yanaka Y. Nogusa N. Fujioka Y. Yamashita Y. Kato N. FEBS Lett. 2007; 581: 712-718Crossref PubMed Scopus (25) Google Scholar). Furthermore, it is reported that GDE3 is regulated during osteoblast development and induces osteoblast differentiation and morphological changes in cultured mammalian cells (13Yanaka N. Imai Y. Kawai E. Akatsuka H. Wakimoto K. Nogusa Y. Kato N. Chiba H. Kotani E. Omori K. Sakurai N. J. Biol. Chem. 2003; 278: 43595-43602Abstract Full Text Full Text PDF PubMed Scopus (38) Google Scholar). In addition, our recent study demonstrates that GDE3 is a GroPIns phosphodiesterase that hydrolyzes GroPIns to glycerol and inositol 1-phosphate, unlike the bacterial GP-PDEs and GDE1 (18Corda D. Kudo T. Zizza P. Iurisci C. Kawai E. Kato N. Yanaka N. Mariggiò S. J. Biol. Chem. 2009; 284: 24848-24856Abstract Full Text Full Text PDF PubMed Scopus (30) Google Scholar). In mammalian cells, GroPIns is being increasingly recognized as an important intracellular messenger that is involved in various cellular signaling pathways such as cell proliferation, transformation, and differentiation (9Corda D. Zizza P. Varone A. Filippi B.M. Mariggiò S. Cell. Mol. Life Sci. 2009; 66: 3449-3467Crossref PubMed Scopus (27) Google Scholar, 18Corda D. Kudo T. Zizza P. Iurisci C. Kawai E. Kato N. Yanaka N. Mariggiò S. J. Biol. Chem. 2009; 284: 24848-24856Abstract Full Text Full Text PDF PubMed Scopus (30) Google Scholar, 19Corda D. Iurisci C. Berrie C.P. Biochim. Biophys. Acta. 2002; 1582: 52-69Crossref PubMed Scopus (75) Google Scholar). Although these observations strongly suggest a central role of mammalian GP-PDEs in regulating intracellular GP concentrations, previous reports on the existence of proteins that interact with mammalian GP-PDEs, such as RGS16, PRAF2 (also known as JM4), and Prdx1 (12Zheng B. Chen D. Farquhar M.G. Proc. Natl. Acad. Sci. U.S.A. 2000; 97: 3999-4004Crossref PubMed Scopus (56) Google Scholar, 20Bachmann A.S. Duennebier F.F. Mocz G. Gene. 2006; 371: 144-153Crossref PubMed Scopus (12) Google Scholar, 21Yan Y. Sabharwal P. Rao M. Sockanathan S. Cell. 2009; 138: 1209-1221Abstract Full Text Full Text PDF PubMed Scopus (88) Google Scholar), have prompted us to consider that GP-PDEs might also act via a non-enzymatic mechanism. Thus, mammalian GP-PDEs are most likely involved in a variety of cellular events (22Yanaka N. Biosci. Biotechnol. Biochem. 2007; 71: 1811-1818Crossref PubMed Scopus (52) Google Scholar). However, at the molecular level, their potential roles remain unclear, including the control of intracellular GP levels and other possible unknown effects.As the characterization of these unidentified GP-PDEs will be highly informative for understanding their molecular basis, we explored novel mammalian GP-PDE cDNAs using sections of the GP-PDE sequence to locate expressed sequence tags (ESTs). For this study, we focused on a cDNA termed GDE5, showing that GDE5 is a novel glycerophosphocholine (GroPCho) phosphodiesterase and also that GDE5 has an inhibitory role in skeletal muscle differentiation that is carried out independently of its GroPCho enzymatic activity.DISCUSSIONIn this study, we have shown that a novel cytosolic GP-PDE, GDE5, selectively hydrolyzes GroPCho. To date, GP-PDEs have been found widely in bacteria, yeast, plants, and mammals. However, different physiological roles among the GP-PDEs have been discussed (10Larson T.J. Ehrmann M. Boos W. J. Biol. Chem. 1983; 258: 5428-5432Abstract Full Text PDF PubMed Google Scholar, 22Yanaka N. Biosci. Biotechnol. Biochem. 2007; 71: 1811-1818Crossref PubMed Scopus (52) Google Scholar, 28Larson T.J. van Loo-Bhattacharya A.T. Arch. Biochem. Biophys. 1988; 260: 577-584Crossref PubMed Scopus (17) Google Scholar, 29Fan X. Goldfine H. Lysenko E. Weiser J.N. Mol. Microbiol. 2001; 41: 1029-1036Crossref PubMed Scopus (52) Google Scholar, 30van der Rest B. Boisson A.M. Gout E. Bligny R. Douce R. Plant Physiol. 2002; 130: 244-255Crossref PubMed Scopus (49) Google Scholar, 31van der Rest B. Rolland N. Boisson A.M. Ferro M. Bligny R. Douce R. Biochem. J. 2004; 379: 601-607Crossref PubMed Google Scholar, 32Fisher E. Almaguer C. Holic R. Griac P. Patton-Vogt J. J. Biol. Chem. 2005; 280: 36110-36117Abstract Full Text Full Text PDF PubMed Scopus (57) Google Scholar, 33Fernández-Murray J.P. McMaster C.R. J. Biol. Chem. 2005; 280: 38290-38296Abstract Full Text Full Text PDF PubMed Scopus (63) Google Scholar). Bacterial GlpQs are well studied and have been shown to have important functions in the hydrolysis of deacylated glycerophospholipids to glycerol phosphate, which is a major source of carbon and phosphate (10Larson T.J. Ehrmann M. Boos W. J. Biol. Chem. 1983; 258: 5428-5432Abstract Full Text PDF PubMed Google Scholar, 28Larson T.J. van Loo-Bhattacharya A.T. Arch. Biochem. Biophys. 1988; 260: 577-584Crossref PubMed Scopus (17) Google Scholar). Previous studies have examined several types of glycerophosphodiesters (derived from glycerophospholipids) as substrates for bacteria GP-PDEs and demonstrated that the bacterial enzymes show broad substrate specificities toward glycerophosphodiesters (10Larson T.J. Ehrmann M. Boos W. J. Biol. Chem. 1983; 258: 5428-5432Abstract Full Text PDF PubMed Google Scholar, 24Ohshima N. Yamashita S. Takahashi N. Kuroishi C. Shiro Y. Takio K. J Bacteriol. 2008; 190: 1219-1223Crossref PubMed Scopus (43) Google Scholar, 28Larson T.J. van Loo-Bhattacharya A.T. Arch. Biochem. Biophys. 1988; 260: 577-584Crossref PubMed Scopus (17) Google Scholar), providing an advantage for the acquisition of glycerol 3-phosphate to be metabolized in bacteria. In contrast, an intriguing feature of mammalian GP-PDEs is that these enzymes show restricted substrate specificities, strongly suggesting the physiological roles of mammalian GP-PDEs as a determinant for GroPIns or GroPCho levels in mammalian cells. GroPIns has been shown to be involved in the control of cell proliferation, cell chemotaxis, and cell morphology, affecting in the last case actin cytoskeletal rearrangements through the activation of small GTPases of the Rho family (9Corda D. Zizza P. Varone A. Filippi B.M. Mariggiò S. Cell. Mol. Life Sci. 2009; 66: 3449-3467Crossref PubMed Scopus (27) Google Scholar, 34Mancini R. Piccolo E. Mariggiò S. Filippi B.M. Iurisci C. Pertile P. Berrie C.P. Corda D. Mol. Biol. Cell. 2003; 14: 503-515Crossref PubMed Scopus (23) Google Scholar, 35Filippi B.M. Mariggiò S. Pulvirenti T. Corda D. Biochim. Biophys. Acta. 2008; 1783: 2311-2322Crossref PubMed Scopus (16) Google Scholar), whereas GroPCho is reportedly an osmoprotective compatible and counteracting organic osmolyte that accumulates in renal inner medullary cells in response to high NaCl and urea (8Gallazzini M. Burg M.B. Physiology. 2009; 24: 245-249Crossref PubMed Scopus (46) Google Scholar, 36Burg M.B. Am. J. Physiol. Renal Physiol. 1995; 268: F983-F996Crossref PubMed Google Scholar, 37Gallazzini M. Ferraris J.D. Kunin M. Morris R.G. Burg M.B. Proc. Natl. Acad. Sci. U.S.A. 2006; 103: 15260-15265Crossref PubMed Scopus (47) Google Scholar). A recent study suggests that GDE2 contributes to osmotic regulation as a GroPCho phosphodiesterase (38Gallazzini M. Ferraris J.D. Burg M.B. Proc. Natl. Acad. Sci. U.S.A. 2008; 105: 11026-11031Crossref PubMed Scopus (59) Google Scholar). This study shows that GDE5 can hydrolyze GroPCho preferentially, suggesting that this novel cytosolic GP-PDE has a role in maintaining the intracellular osmotic balance by regulating intracellular the study, we have demonstrated that GDE5 skeletal muscle differentiation. is that GDE5 expression in skeletal muscle was in several types of skeletal muscle previous studies have of skeletal muscle during disuse, and aging J. Clin. Nutr. PubMed Scopus Google Scholar), the decreased GDE5 expression might an response to the we have shown that the GDE5 inhibitory role is not to its GroPCho phosphodiesterase Previous studies using have shown that mammalian GP-PDEs have the potential to interact with intracellular proteins (12Zheng B. Chen D. Farquhar M.G. Proc. Natl. Acad. Sci. U.S.A. 2000; 97: 3999-4004Crossref PubMed Scopus (56) Google Scholar, 20Bachmann A.S. Duennebier F.F. Mocz G. Gene. 2006; 371: 144-153Crossref PubMed Scopus (12) Google Scholar). Y. Sabharwal P. Rao M. Sockanathan S. Cell. 2009; 138: 1209-1221Abstract Full Text Full Text PDF PubMed Scopus (88) Google recently a of a mammalian GP-PDE, that GDE2 with the and with Prdx1 to neuronal differentiation. These observations that mammalian GP-PDEs intracellular proteins in the control of cellular studies, which the of that interact with will be to the of other potential of transgenic mice specifically expressing GDE5ΔC471 in skeletal muscle and showed that GDE5ΔC471 mice have less type II fiber-rich muscle Previous studies have the of changes in skeletal muscle in pathological and physiological expression of several involved in in GDE5ΔC471 skeletal muscle is similar to the types of skeletal muscle atrophy by of the H. Y. D. F. C. J. M. J. G. M. W. J. 2007; PubMed Scopus (49) Google Scholar, C. 2008; PubMed Scopus Google Scholar). as shown in it is that the expression of the enzymes and was decreased in the GDE5ΔC471 muscle. Previous studies have demonstrated that physical exercise metabolism in skeletal muscle Stein J. J. Clin. 2000; PubMed Scopus (27) Google Scholar, A.M. C. Plant J.D. J. 2008; PubMed Scopus Google Scholar). is possible that of synthesis is involved in the in GDE5ΔC471 skeletal muscle. In most types of skeletal muscle such as and the of protein synthesis are suppressed and the of protein degradation are this response for the of the of muscle protein Mol. 2003; Full Text Full Text PDF PubMed Scopus Google Scholar, Am. J. Physiol. Physiol. 2004; PubMed Scopus Google Scholar). In and most of the in skeletal muscle to be to an activation of the by in levels of the and which are enzymes in the A. M. J. J. 2004; PubMed Scopus Google Scholar, T. K. K. I. M. M. E. I. T. N. K. S. J. 2004; PubMed Scopus Google Scholar, Y. S. M. Y. J. T. K. T. J. H. I. J. Biol. Chem. 2004; Full Text Full Text PDF PubMed Scopus Google Scholar). In GDE5ΔC471 levels for enzymes involved in the and not from the suggesting that protein degradation of skeletal muscle is not involved in the of GDE5ΔC471 muscles. this in study demonstrated that the expression of a variety of such as and is in GDE5ΔC471 muscle. studies have demonstrated novel biological roles of in and via the signaling and in the of glucose through a distinct from the signaling F. D. J. T. S. W. J. Biol. Chem. 2008; Full Text Full Text PDF PubMed Scopus (26) Google Scholar, W. W. Y. FEBS J. 2009; PubMed Scopus (27) Google Scholar). we have shown that of GDE5ΔC471 mice were as with controls suggesting that the proteins from skeletal muscle of the GDE5ΔC471 mice can functions and mass with Furthermore, M. PubMed Scopus Google showed that is a cell involved in motor and development. Thus, GDE5ΔC471 mice not will to an understanding of the in functions of GDE5 via a non-enzymatic but they will also be as a novel of type II fiber-rich skeletal muscle that can be used to for in skeletal this study a insight into the role of mammalian GP-PDEs, of their enzymatic also has prompted us to consider the between and biological significance of and mammalian GP-PDEs at the molecular level. IntroductionThe mass and composition of skeletal muscle are closely associated with its physiological functions, such as exercise, energy expenditure, and glucose metabolism (1Zurlo F. Larson K. Bogardus C. Ravussin E. J. Clin. Investig. 1990; 86: 1423-1427Crossref PubMed Scopus (621) Google Scholar, 2Berchtold M.W. Brinkmeier H. Müntener M. Physiol. Rev. 2000; 80: 1215-1265Crossref PubMed Scopus (682) Google Scholar). Progressive muscle loss, frequently caused by diabetes, obesity, and decreased physical activity (sarcopenia), is a major health problem in our aging society (3Proctor D.N Balagopal P Nair K.S J. Nutr. 1998; 128: S351-S355Crossref PubMed Google Scholar). In the search for clues as to the regulation of skeletal muscle mass and composition during physical exercise and muscular atrophy caused by disease and disuse, a number of metabolites have been investigated in adult skeletal muscles. In human and mouse skeletal muscle tissues, deacylated glycerophospholipids, the glycerophosphodiesters (GPs), 3The abbreviations used are: GPglycerophosphodiesterGP-PDEglycerophosphodiester phosphodiesteraseGroPInsglycerophosphoinositolGroPChoglycerophosphocholineESTexpressed sequence tagG3Pglycerol 3-phosphateMBPmaltose-binding protein. were analyzed as phosphate-containing compounds, and interestingly, the amounts of skeletal muscle GPs are reportedly altered in response to physical activity, the environment, and pathological conditions (4Burt C.T. Glonek T. Bárány M. Biochemistry. 1976; 15: 4850-4853Crossref PubMed Scopus (110) Google Scholar, 5Younkin D.P. Berman P. Sladky J. Chee C. Bank W. Chance B. Neurology. 1987; 37: 165-169Crossref PubMed Google Scholar, 6Sprott H. Rzanny R. Reichenbach J.R. Kaiser W.A. Hein G. Stein G. Rheumatology. 2000; 39: 1121-1125Crossref PubMed Scopus (39) Google Scholar). However, the biological functions of skeletal muscle GPs and the physiological regulation of their levels have not been studied to date.The GPs (primarily glycerophosphoinositol and glycerophosphocholine) are cellular products of phospholipase activities on membrane phospholipids. GP intracellular concentrations vary with oncogenic transformation, cell differentiation, and environmental stimuli, and they are thought to be tightly controlled for the balance between synthesis and degradation (7Baburina I. Jackowski S. J. Biol. Chem. 1999; 274: 9400-9408Abstract Full Text Full Text PDF PubMed Scopus (165) Google Scholar, 8Gallazzini M. Burg M.B. Physiology. 2009; 24: 245-249Crossref PubMed Scopus (46) Google Scholar, 9Corda D. Zizza P. Varone A. Filippi B.M. Mariggiò S. Cell. Mol. Life Sci. 2009; 66: 3449-3467Crossref PubMed Scopus (27) Google Scholar). For GP hydrolysis, two bacterial enzymes have been isolated and studied in depth at the molecular level. Glycerophosphodiester phosphodiesterases (GP-PDEs), GlpQ and UgpQ, were identified as periplasmic and cytosolic proteins that have essential roles in the hydrolysis of GPs to glycerol 3-phosphate and alcohol, which are used as major sources of carbon and phosphate (10Larson T.J. Ehrmann M. Boos W. J. Biol. Chem. 1983; 258: 5428-5432Abstract Full Text PDF PubMed Google Scholar, 11Tommassen J. Eiglmeier K. Cole S.T. Overduin P. Larson T.J. Boos W. Mol Gen Genet. 1991; 226: 321-327Crossref PubMed Scopus (71) Google Scholar). In contrast, three mammalian GP-PDEs, GDE1, GDE2, and GDE3, were previously identified and presumed to have distinct physiological functions (12Zheng B. Chen D. Farquhar M.G. Proc. Natl. Acad. Sci. U.S.A. 2000; 97: 3999-4004Crossref PubMed Scopus (56) Google Scholar, 13Yanaka N. Imai Y. Kawai E. Akatsuka H. Wakimoto K. Nogusa Y. Kato N. Chiba H. Kotani E. Omori K. Sakurai N. J. Biol. Chem. 2003; 278: 43595-43602Abstract Full Text Full Text PDF PubMed Scopus (38) Google Scholar, 14Nogusa Y. Fujioka Y. Komatsu R. Kato N. Yanaka N. Gene. 2004; 337: 173-179Crossref PubMed Scopus (26) Google Scholar, 15Rao M. Sockanathan S. Science. 2005; 309: 2212-2215Crossref PubMed Scopus (69) Google Scholar). In initial studies, GDE1 (also known as MIR16) was isolated as a unique membrane protein that interacted with RGS16, a regulator of G-protein signaling (12Zheng B. Chen D. Farquhar M.G. Proc. Natl. Acad. Sci. U.S.A. 2000; 97: 3999-4004Crossref PubMed Scopus (56) Google Scholar), and it has been shown to preferentially hydrolyze glycerophosphoinositol (GroPIns) in response to β-adrenergic stimulation (16Zheng B. Berrie C.P. Corda D. Farquhar M.G. Proc. Natl. Acad. Sci. U.S.A. 2003; 100: 1745-1750Crossref PubMed Scopus (69) Google Scholar). Studies on GDE2 show that retinoic acid-induced expression of GDE2 has critical roles in neuronal differentiation and neurite outgrowth of motor neurons (15Rao M. Sockanathan S. Science. 2005; 309: 2212-2215Crossref PubMed Scopus (69) Google Scholar, 17Yanaka Y. Nogusa N. Fujioka Y. Yamashita Y. Kato N. FEBS Lett. 2007; 581: 712-718Crossref PubMed Scopus (25) Google Scholar). Furthermore, it is reported that GDE3 is regulated during osteoblast development and induces osteoblast differentiation and morphological changes in cultured mammalian cells (13Yanaka N. Imai Y. Kawai E. Akatsuka H. Wakimoto K. Nogusa Y. Kato N. Chiba H. Kotani E. Omori K. Sakurai N. J. Biol. Chem. 2003; 278: 43595-43602Abstract Full Text Full Text PDF PubMed Scopus (38) Google Scholar). In addition, our recent study demonstrates that GDE3 is a GroPIns phosphodiesterase that hydrolyzes GroPIns to glycerol and inositol 1-phosphate, unlike the bacterial GP-PDEs and GDE1 (18Corda D. Kudo T. Zizza P. Iurisci C. Kawai E. Kato N. Yanaka N. Mariggiò S. J. Biol. Chem. 2009; 284: 24848-24856Abstract Full Text Full Text PDF PubMed Scopus (30) Google Scholar). In mammalian cells, GroPIns is being increasingly recognized as an important intracellular messenger that is involved in various cellular signaling pathways such as cell proliferation, transformation, and differentiation (9Corda D. Zizza P. Varone A. Filippi B.M. Mariggiò S. Cell. Mol. Life Sci. 2009; 66: 3449-3467Crossref PubMed Scopus (27) Google Scholar, 18Corda D. Kudo T. Zizza P. Iurisci C. Kawai E. Kato N. Yanaka N. Mariggiò S. J. Biol. Chem. 2009; 284: 24848-24856Abstract Full Text Full Text PDF PubMed Scopus (30) Google Scholar, 19Corda D. Iurisci C. Berrie C.P. Biochim. Biophys. Acta. 2002; 1582: 52-69Crossref PubMed Scopus (75) Google Scholar). Although these observations strongly suggest a central role of mammalian GP-PDEs in regulating intracellular GP concentrations, previous reports on the existence of proteins that interact with mammalian GP-PDEs, such as RGS16, PRAF2 (also known as JM4), and Prdx1 (12Zheng B. Chen D. Farquhar M.G. Proc. Natl. Acad. Sci. U.S.A. 2000; 97: 3999-4004Crossref PubMed Scopus (56) Google Scholar, 20Bachmann A.S. Duennebier F.F. Mocz G. Gene. 2006; 371: 144-153Crossref PubMed Scopus (12) Google Scholar, 21Yan Y. Sabharwal P. Rao M. Sockanathan S. Cell. 2009; 138: 1209-1221Abstract Full Text Full Text PDF PubMed Scopus (88) Google Scholar), have prompted us to consider that GP-PDEs might also act via a non-enzymatic mechanism. Thus, mammalian GP-PDEs are most likely involved in a variety of cellular events (22Yanaka N. Biosci. Biotechnol. Biochem. 2007; 71: 1811-1818Crossref PubMed Scopus (52) Google Scholar). However, at the molecular level, their potential roles remain unclear, including the control of intracellular GP levels and other possible unknown effects.As the characterization of these unidentified GP-PDEs will be highly informative for understanding their molecular basis, we explored novel mammalian GP-PDE cDNAs using sections of the GP-PDE sequence to locate expressed sequence tags (ESTs). For this study, we focused on a cDNA termed GDE5, showing that GDE5 is a novel glycerophosphocholine (GroPCho) phosphodiesterase and also that GDE5 has an inhibitory role in skeletal muscle differentiation that is carried out independently of its GroPCho enzymatic
42
Skeletal muscle metabolism is a major determinant of resting energy expenditure.
F. Zurlo, K. A. Larson, Clifton Bogardus et al. · Journal of Clinical Investigation · 1990 · 977 citations · Full text
Life Sciences, Nutrition, Physiology +15